(Philadelphia, PA) - Jeanne M. Manson, PhD, MSCE, has joined the Department of Pediatrics at the University of Pennsylvania School of Medicine, as an Associate Professor. She is also a Research Scientist in the Division of Human Genetics & Molecular Biology at The Children's Hospital of Philadelphia.

Dr. Manson's area of research is molecular epidemiology of birth defects, specifically gene-environment interaction in the causation of developmental defects. She has been published in the peer-reviewed publications, Developmental Biology, Teratology, Toxicology, the Journal of Embryological Experimental Morphology and Environmental Research.

Dr. Manson earned her BA in Biology and Chemistry from Emmanuel College in Boston. She went on to receive her PhD in Developmental Biology from Ohio State University and her Master of Science in Clinical Epidemiology (MSCE) from the University of Pennsylvania. Prior to her appointment at the University of Pennsylvania School of Medicine, she was a Research Professor in the Department of Obstetrics and Gynecology at Thomas Jefferson University in Philadelphia.

Among her many awards, honors and memberships, Dr. Manson has received a Scientific Achievement Award from the Society of Toxicology and is a diplomate in General Toxicology appointed by the Academy of Toxicological Sciences. She serves as a consultant to the Federal Drug Administration (FDA) on labeling of drugs for use in pregnancy and pregnancy registries and as a consultant to the American Chemistry Council's Endocrine Technical Implementation panel. Dr. Manson is also an Associate Editor for the publication, Birth Defects Research.

# # #


Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.